{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:57:41Z","timestamp":1787237861853,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T00:00:00Z","timestamp":1657584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR2055B"],"award-info":[{"award-number":["SHDC2020CR2055B"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["20410760500"],"award-info":[{"award-number":["20410760500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC201803"],"award-info":[{"award-number":["2018YFC201803"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>\n                    Glycolipid metabolic diseases, including type 2 diabetes, non-alcoholic fatty liver disease, obesity, hypertension, dyslipidemia, and atherosclerosis, which have become a major public health concern worldwide, are mainly triggered by\n                    <jats:italic>hepatic glycolipid metabolism<\/jats:italic>\n                    disorder. Bibliometric analysis has provided a comprehensive review of developments in\n                    <jats:italic>hepatic glycolipid metabolism<\/jats:italic>\n                    research and changes in research hotspots over the past 20 years. The articles regarding\n                    <jats:italic>hepatic glycolipid metabolism<\/jats:italic>\n                    from 2002 to 2021 were identified from the Science Citation Index-Expanded of Web of Science Core Collection. Acquired data were then processed by the CiteSpace software and the Online Analysis Platform of Literature Metrology to analyze trends and predict hot spots in this field. A total of 4,856 articles regarding\n                    <jats:italic>hepatic glycolipid metabolism<\/jats:italic>\n                    published from 2002 to 2021 were selected. The leading country was China. The Chinese Academy of Sciences was the most productive institution. Co-citation cluster labels revealed characteristics of ten main clusters: non-alcoholic fatty liver disease, gut microbiota, adiponectin, fructose, fgf21, fatty acid, liver x receptor, nr4a, obese mice, and bile acids. Keyword bursts analysis indicated that management, non-alcoholic fatty liver disease, and modulation were the newly emerging research hot spots. We described the overall structure of scientific research on\n                    <jats:italic>hepatic glycolipid metabolism<\/jats:italic>\n                    and presented systematic information to other researchers. The current focus on NAFLD and gut microbiota is critical to further study and will help explore effective therapeutic strategy for aberrant glycolipid metabolism in liver.\n                  <\/jats:p>","DOI":"10.3389\/fnut.2022.933211","type":"journal-article","created":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T12:50:21Z","timestamp":1657630221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Emerging Trends and Hot Spots in Hepatic Glycolipid Metabolism Research From 2002 to 2021: A Bibliometric Analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Yanyu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqing","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingfu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1002\/hep.31881","article-title":"Hepatic small ubiquitin-related modifier (SUMO)-specific protease 2 controls systemic metabolism through sumoylation-dependent regulation of liver-adipose tissue crosstalk","volume":"74","author":"Liu","year":"2021","journal-title":"Hepatology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.7150\/thno.27425","article-title":"miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3","volume":"8","author":"Xu","year":"2018","journal-title":"Theranostics."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jhep.2020.07.048","article-title":"miR-552-3p modulates transcriptional activities of FXR and LXR to ameliorate hepatic glycolipid metabolism disorder","volume":"74","author":"Fan","year":"2021","journal-title":"J Hepatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41374-021-00715-1","article-title":"SIRT6 regulates SREBP1c-induced glucolipid metabolism in liver and pancreas via the AMPKalpha-mTORC1 pathway","volume":"102","author":"Bian","year":"2021","journal-title":"Lab Invest."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nm.4412","article-title":"Activation of intestinal hypoxia-inducible factor 2alpha during obesity contributes to hepatic steatosis","volume":"23","author":"Xie","year":"2017","journal-title":"Nat Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"142936","DOI":"10.1016\/j.scitotenv.2020.142936","article-title":"Decabromodiphenyl ether disturbs hepatic glycolipid metabolism by regulating the PI3K\/AKT\/GLUT4 and mTOR\/PPARgamma\/RXRalpha pathway in mice and L02 cells","volume":"763","author":"Zhu","year":"2021","journal-title":"Sci Total Environ."},{"key":"B7","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: Focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J Hepatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.3390\/ijms22094495","article-title":"Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC","volume":"22","author":"Kim","year":"2021","journal-title":"Int J Mol Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.aav3722","article-title":"Targeting a ceramide double bond improves insulin resistance and hepatic steatosis","volume":"365","author":"Chaurasia","year":"2019","journal-title":"Science."},{"key":"B11","doi-asserted-by":"publisher","first-page":"153139","DOI":"10.1016\/j.phymed.2019.153139","article-title":"Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes","volume":"67","author":"Xu","year":"2020","journal-title":"Phytomedicine."},{"key":"B12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/nu14030542","article-title":"Bibliometric Analysis of Global Research Productivity on Vitamin D and Bone Metabolism (2001-2020): Learn from the Past to Plan Future","volume":"14","author":"Malik","year":"2022","journal-title":"Nutrients."},{"key":"B13","doi-asserted-by":"publisher","first-page":"104608","DOI":"10.1016\/j.neubiorev.2022.104608","article-title":"Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends","volume":"136","author":"Sabe","year":"2022","journal-title":"NeurosciBiobehav Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1024940629314","article-title":"Bursty and Hierarchical Structure in Streams","volume":"7","author":"Kleinberg","year":"2003","journal-title":"Data Min Knowl Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"683232","DOI":"10.3389\/fonc.2021.683232","article-title":"A 20-Year Research Trend Analysis of the Influence of Anesthesia on Tumor Prognosis Using Bibliometric Methods","volume":"11","author":"Luo","year":"2021","journal-title":"Front Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/cphy.c130024","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell."},{"key":"B19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14712598.2012.674507","article-title":"Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace","volume":"12","author":"Chen","year":"2012","journal-title":"Expert Opin Biol Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.21037\/qims.2019.02.10","article-title":"A scientometric analysis on hepatocellular carcinoma magnetic resonance imaging research from 2008 to 2017","volume":"9","author":"Yang","year":"2019","journal-title":"Quant Imaging Med Surg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.3390\/nu7075232","article-title":"Anti-diabetic and hepato-renal protective effects of ziyuglycoside II methyl ester in type 2 diabetic mice","volume":"7","author":"Son","year":"2015","journal-title":"Nutrients."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8628027","DOI":"10.1155\/2019\/8628027","article-title":"Human umbilical cord-derived mesenchymal stem cell therapy ameliorates nonalcoholic fatty liver disease in obese type 2 diabetic mice","volume":"2019","author":"Li","year":"2019","journal-title":"Stem Cells Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"172393","DOI":"10.1016\/j.ejphar.2019.05.022","article-title":"Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR\/Nrf2 signaling in db\/db mice","volume":"858","author":"Wu","year":"2019","journal-title":"Eur J Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1039\/D0FO00180E","article-title":"Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice","volume":"11","author":"Zhao","year":"2020","journal-title":"Food Funct."},{"key":"B25","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","article-title":"New trends on obesity and NAFLD in Asia","volume":"67","author":"Fan","year":"2017","journal-title":"J Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jfma.2020.07.006","article-title":"Non-alcoholic fatty liver disease: A review with clinical and pathological correlation","volume":"120","author":"Chen","year":"2021","journal-title":"J Formos Med Assoc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/hep.24810","article-title":"Caveolin-1 orchestrates the balance between glucose and lipid-dependent energy metabolism: implications for liver regeneration","volume":"55","author":"Fernandez-Rojo","year":"2012","journal-title":"Hepatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","article-title":"Dietary lipids, gut microbiota and lipid metabolism","volume":"20","author":"Schoeler","year":"2019","journal-title":"Rev EndocrMetabDisord."},{"key":"B30","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.933211\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T12:50:24Z","timestamp":1657630224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.933211\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":30,"alternative-id":["10.3389\/fnut.2022.933211"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.933211","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,12]]},"article-number":"933211"}}